The spread of carbapenem-resistant gram negatives is a global emergency, and surveillance of new resistant clones is critical from both public health and clinical standpoints. Herein, we describe the emergence of a KPC-3-producing Escherichia coli ST69 as a cause of bloodstream infection in two Italian patients.
Get full access to this article
View all access options for this article.
References
1.
AccogliM., GianiT., MonacoM., GiufrèM., García-FernándezA., ConteV., D'AnconaF., PantostiA., RossoliniG.M., and CerquettiM.. 2014. Emergence of Escherichia coli ST131 sub-clone H30 producing VIM-1 and KPC-3 carbapenemases, Italy. J. Antimicrob. Chemother., 69:2293–2296.
2.
Adams-SapperS., DiepB.A., Perdreau-RemingtonF., and RileyL.W.. 2013. Clonal composition and community clustering of drug-susceptible and resistant Escherichia coli isolates from blood stream infections. Antimicrob. Agents Chemother., 57:490–497.
3.
BratuS., LandmanD., HaagR., ReccoR., EramoA., AlamM., and QualeJ.. 2005. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch. Intern. Med., 165:1430–1435.
4.
BulikC.C., FauntleroyK.A., JenkinsS.G., AbauliM., LaBombardiV.J., NicolauD.P., and KutiJ.L.. 2010. Comparison of meropenem MICs and susceptibilities for carbapenemase-producing Klebsiella pneumoniae isolates by various testing methods. J. Clin. Microbiol., 48:2402–2406.
5.
CagnacciS., GualcoL., DebbiaE., SchitoG.C., and MarcheseA.. 2008. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J. Clin. Microbiol., 46:2605–2612.
6.
CoppoE., Del BonoV., VenturaF., CameraM., OrengoG., ViscoliC., and MarcheseA.. 2014. Identification of a New Delhi metallo- β-lactamase-4 (NDM-4)- producing Escherichia coli in Italy. BMC Microbiol., 14:148.
7.
DortetL., PoirelL., and NordmannP.. 2012. Rapid identification of carbapenemase types in Enterobacteriaceae and Pseudomonas spp. by using a biochemical test. Antimicrob. Agents Chemother., 56:6437–6440.
8.
GonaF., BarberaF., PasquarielloA.C., GrossiP., GridelliB., MezzatestaM.L., CaioC., StefaniS., and ConaldiP.G.. 2014. In vivo multiclonal transfer of blaKPC-3 from Klebsiella pneumoniae to Escherichia coli in surgery patients. Clin. Microbiol. Infect. [Epub ahead of print]; DOI: 10.1111/1469-0691.12577.
9.
MangesA.R., JohnsonJ.R., FoxmanB., O'BryanT.T., FullertonK.E., and RileyL.W.. 2001. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N. Engl. J. Med., 345:1007–1013.
10.
MarcheseA., CoppoE., and BarbieriR.. 2010. Emergence of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains and spread of an isolate of sequence type 258 in the neuro-rehabilitation unit of an Italian hospital. J. Chemother., 22:212–214.
11.
NordmannP., DortetL., and PoirelL.. 2012. Carbapenem resistance in Enterobacteriaceae: here is the storm!. Trends Mol. Med., 18:263–272.
12.
NordmannP., NaasT., and PoirelL.. 2011. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis., 17:1791–1798.
13.
PontikisK., KaraiskosI., BastaniS., DimopoulosG., KalogirouM., KatsiariM., OikonomouA., PoulakouG., RoilidesE., and GiamarellouH.. 2013. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria. Int. J. Antimicrob. Agents., 43:52–95.
14.
Porres-OsanteN., Azcona-GutiérrezJ.M., Rojo-BezaresB., UndabeitiaE., TorresC., and SáenzY.. 2014. Emergence of a multiresistant KPC-3 and VIM-1 carbapenemase-producing Escherichia coli strain in Spain. J. Antimicrob. Chemother., 69:1792–1795.
15.
QureshiZ.A., PatersonD.L., PotoskiB.A., KilaykoM.C., SandovskyG., SordilloE., PolskyB., Adams-HaduchJ.M., and DoiY.. 2012. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob. Agents Chemother., 56:2108–2113.
16.
RichterS.N., et al.2011. Transfer of KPC-2 Carbapenemase from Klebsiella pneumoniae to Escherichia coli in a patient: first case in Europe. J. Clin. Microbiol., 49:2040–2042.
17.
TacconelliE., CataldoM.A., DancerS.J., De AngelisG., FalconeM., FrankU., KahlmeterG., PanA., PetrosilloN., Rodríguez-BañoJ., SinghN., VendittiM., YokoeD.S., CooksonB., and the European Society of Clinical Microbiology. 2014. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin. Microbiol. Infect., S1:1–55.
18.
TumbarelloM., VialeP., ViscoliC., TrecarichiE.M., TumiettoF., MarcheseA., SpanuT., AmbrettiS., GinocchioF., CristiniF., LositoA.R., TedeschiS., CaudaR., and BassettiM.. 2012. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin. Infect. Dis., 55:943–950.
